EyePoint Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
WATERTOWN, Mass., Dec. 20, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, today announced that Jay S. Duker, M.D., President and Chief Executive Officer of EyePoint Pharmaceuticals will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 10:30 a.m. PT/1:30 p.m. ET.
Related news for (EYPT)
- Breaking News: MoBot’s Latest Update as of 05/28/25 12:00 PM
- eyepoint pharmaceuticals announces closing of upsized public offering and full exercise of option to purchase additional shares
- eyepoint pharmaceuticals announces pricing of upsized public offering
- eyepoint pharmaceuticals announces proposed public offering of common stock
- 24/7 Market News Snapshot 28 October, 2024 – EyePoint Pharmaceuticals, Inc. Common Stock (NASDAQ:EYPT)